Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,166 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pravastatin and cardiovascular risk in moderate chronic kidney disease.
Nakamura H, Mizuno K, Ohashi Y, Yoshida T, Hirao K, Uchida Y; MEGA Study Group. Nakamura H, et al. Among authors: ohashi y. Atherosclerosis. 2009 Oct;206(2):512-7. doi: 10.1016/j.atherosclerosis.2009.03.031. Epub 2009 Apr 5. Atherosclerosis. 2009. PMID: 19423108 Clinical Trial.
Pravastatin reduces the risk for cardiovascular disease in Japanese hypercholesterolemic patients with impaired fasting glucose or diabetes: diabetes subanalysis of the Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA) Study.
Tajima N, Kurata H, Nakaya N, Mizuno K, Ohashi Y, Kushiro T, Teramoto T, Uchiyama S, Nakamura H; Primary Prevention Group of Adult Japanese (MEGA) Study. Tajima N, et al. Among authors: ohashi y. Atherosclerosis. 2008 Aug;199(2):455-62. doi: 10.1016/j.atherosclerosis.2008.05.027. Epub 2008 May 28. Atherosclerosis. 2008. PMID: 18635188
Risk factors for stroke and lipid-lowering effect of pravastatin on the risk of stroke in Japanese patients with hypercholesterolemia: analysis of data from the MEGA Study, a large randomized controlled trial.
Uchiyama S, Nakaya N, Mizuno K, Ohashi Y, Tajima N, Kushiro T, Teramoto T, Nakamura H; MEGA Study Group. Uchiyama S, et al. Among authors: ohashi y. J Neurol Sci. 2009 Sep 15;284(1-2):72-6. doi: 10.1016/j.jns.2009.04.002. Epub 2009 May 6. J Neurol Sci. 2009. PMID: 19423132
Association between lowering low-density lipoprotein cholesterol with pravastatin and primary prevention of cardiovascular disease in mild to moderate hypercholesterolemic Japanese.
Teramoto T, Nakaya N, Yokoyama S, Ohashi Y, Mizuno K, Nakamura H; MEGA Study Group. Teramoto T, et al. Among authors: ohashi y. J Atheroscler Thromb. 2010 Aug 31;17(8):879-87. doi: 10.5551/jat.4176. Epub 2010 Jun 11. J Atheroscler Thromb. 2010. PMID: 20543522 Free article. Clinical Trial.
Low-dose pravastatin and age-related differences in risk factors for cardiovascular disease in hypercholesterolaemic Japanese: analysis of the management of elevated cholesterol in the primary prevention group of adult Japanese (MEGA study).
Nakaya N, Mizuno K, Ohashi Y, Teramoto T, Yokoyama S, Hirahara K, Mizutani M, Nakamura H; MEGA Study Group. Nakaya N, et al. Among authors: ohashi y. Drugs Aging. 2011 Sep 1;28(9):681-92. doi: 10.2165/11595620-000000000-00000. Drugs Aging. 2011. PMID: 21815708 Clinical Trial.
Usefulness of pravastatin in primary prevention of cardiovascular events in women: analysis of the Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA study).
Mizuno K, Nakaya N, Ohashi Y, Tajima N, Kushiro T, Teramoto T, Uchiyama S, Nakamura H; MEGA Study Group. Mizuno K, et al. Among authors: ohashi y. Circulation. 2008 Jan 29;117(4):494-502. doi: 10.1161/CIRCULATIONAHA.106.671826. Epub 2008 Jan 2. Circulation. 2008. PMID: 18172039 Clinical Trial.
2,166 results